target audience: TECH SUPPLIER Publication date: Sep 2023 - Document type: IDC Survey - Doc Document number: # AP50548723
IDC's 2023 Life Sciences Digital Transformation Survey: Asia/Pacific (Including Japan) Perspectives
This IDC Survey analysis highlights the key trends in the life sciences (LS) from IDC's 2023 LS Digital Transformation Survey conducted in North America and Asia/Pacific to understand the current status of digital transformation initiatives in LS organizations today. This report focuses on the 41 LS organizations from Asia/Pacific out of 250 respondents.
The goal of the survey is to understand how digital transformation is impacting the LS value chain, key use cases with maximum ROI, industry building versus buying, and LS organizations' technology adoption maturity curve.
This presentation looks at investments in specific technologies to scale digital transformation, current challenges organizations are facing, and the current adoption rate of generative AI among LS organizations.
"LS in Asia/Pacific is moving toward innovation, with over three quarters of the respondents undergoing digital transformation. Although they prioritize decentralized clinical trials and faster drug design, generative AI has opened a new phase of accelerated innovation that organizations will leverage for new capabilities, including developing precision drugs, augmenting workflow efficiency, and enhancing patient experience. Moving forward, there will be an increased focus on cybersecurity measures and key performance indicator (KPI)–based partnership ecosystems to keep the digital transformation system strong and running," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Health Insights.